Society ❯ Health Issues ❯ Obesity

Weight Management

Public Health Pharmaceutical Solutions Drug Accessibility Treatment Options Medication Use Medication Accessibility Dieting Trends Weight-loss Drugs Drug Dependency Consumer Health Community Support Patient Experiences GLP-1 Drugs Medication Abuse Dietary Treatments Dietary Medications Access to Medication Patient Care Wegovy Injectable Treatments Personal Experiences Mounjaro Public Health Initiatives Dietary Supplements Public Perception of Weight Loss Drug Affordability Lifestyle Changes Dietary Interventions Patient Eligibility Public Health Policies

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

The move signals the agency sees no clinical need for bulk versions given improved supply.

States Curb Medicaid Coverage as First GLP‑1 Weight‑Loss Pill Debuts and Cash Prices Fall

Trump Pledges Sharp Cuts to GLP-1 Drug Prices as Novo, Lilly Shares Slide